CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 185 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Cash flows from operating activities:      
Net loss $ (2,473,906) $ (2,555,766) $ (86,620,825)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 21,415 29,780 2,470,830
Amortization of debt discount 382,478 304,167 2,376,855
Gain on disposal of property and equipment     (21,663)
Gain on extinguishment of debt     (216,617)
Interest expense paid with Series B Preferred Stock in connection with conversion of notes payable     3,147
Abandoned patents     183,556
Bad debts - employee advances     255,882
Contributed technology expense     4,550,000
Consulting expense     237,836
Management unit expense     1,334,285
Expense for issuance of warrants     533,648
Expense for issuance of options 4,532 178,069 2,509,592
Amortization of deferred compensation     74,938
Penalties in connection with non-registration event     361,496
Changes in operating assets and liabilities:      
Accounts receivable (7,316)   (43,394)
Inventories (104,236)   (535,258)
Prepaid expenses and other current assets (102,340) 308,923 (417,616)
Other assets     (56,394)
Accounts payable and accrued expenses 60,581 114,268 3,018,437
Accrued interest expense     1,823,103
Net cash used by operating activities (2,218,792) (1,620,559) (64,796,201)
Cash flows from investing activities:      
Proceeds from sale of property and equipment     32,491
Purchases of property and equipment (1,065) (17,065) (2,402,025)
Patent costs (24,957) (11,333) (504,515)
Purchases of short-term investments     (393,607)
Proceeds from sale of short-term investments     393,607
Loan receivable     (1,632,168)
Net cash used by investing activities (26,022) (28,398) (4,506,217)
Cash flows from financing activities:      
Proceeds from issuance of common stock     400,490
Proceeds from issuance of preferred stock     9,579,040
Equity contributions - net of fees incurred 2,100,000 2,756,860 48,671,310
Proceeds from borrowings 700,000 1,250,000 11,888,881
Proceeds from subscription receivables   2,953 499,395
Proceeds from exercise of stock options     5,141
Net cash provided by financing activities 2,800,000 4,009,813 71,044,257
Net change in cash and cash equivalents 555,186 2,360,856 1,741,839
Cash and cash equivalents - beginning of period 1,186,653 1,055,669  
Cash and cash equivalents - end of period 1,741,839 3,416,525 1,741,839
Supplemental disclosure of cash flow information:      
Cash paid during the period for interest     590,189
Supplemental schedule of noncash investing and financing activities:      
Debt discount in connection with issuance of convertible debt 87,700 1,250,000 1,644,505
Fair value of shares issued as costs of raising capital 213,584 106,344 549,534
Issuance of 5,666,616 shares of common stock pursuant to cashless exercise of warrants         
Note payable principal and interest conversion to equity 395,153 882,900 12,344,602
Change in fair value of management units for cost of raising capital     278,087
Issuance of common stock in exchange for stock subscribed     399,395
Costs paid from proceeds in conjunction with issuance preferred stock     768,063
Preferred stock dividends 1,241,121 1,619,571 9,651,744
Net effect of conversion of common stock to preferred stock prior to merger     559
Convertible Notes Payable And Accrued Interest
     
Adjustments to reconcile net loss to net cash used in operating activities:      
Issuance of common stock     3,351,961
Consultant Services
     
Adjustments to reconcile net loss to net cash used in operating activities:      
Issuance of common stock     30,000
Leasehold Improvements
     
Supplemental schedule of noncash investing and financing activities:      
Issuance of member units     141,635
Stock Issuance Costs
     
Supplemental schedule of noncash investing and financing activities:      
Issuance of member units     437,206
Loans Receivable
     
Supplemental schedule of noncash investing and financing activities:      
Issuance of member units     1,632,168
Accounts Payable
     
Supplemental schedule of noncash investing and financing activities:      
Issuance of member units     $ 1,614,446